US Broker Ratings

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking a 103.67% Potential Upside

Telix Pharmaceuticals Limited (TLX), a key player in the biotechnology sector, captures investor attention with its promising radiopharmaceutical developments. Headquartered in North Melbourne, Australia, the company..

Ionis Pharmaceuticals (IONS) Stock Analysis: A Biotech Pioneer with 33% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is a frontrunner in the biotechnology sector, renowned for its pioneering RNA-targeted medicines. With a market capitalization of $12.51 billion, Ionis..

Teleflex Incorporated (TFX) Stock Analysis: A Look at the Healthcare Innovator’s 7.97% Potential Upside

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector specializing in medical instruments and supplies, catches the eye of investors with a notable potential..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Analyzing a 33% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stands out in the biotechnology sector with a significant market cap of $11.76 billion. This Pennsylvania-based company is at the forefront..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Strategic Hold in the Biotech Space with Steady Potential

Soleno Therapeutics, Inc. (SLNO) is making waves in the biotechnology industry as it focuses on developing treatments for rare diseases, with its lead product candidate being..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 24.88% Potential Upside in the Biotech Sector

Roivant Sciences Ltd. (ROIV), a UK-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a strong focus on innovative medicines and technologies. As..

Stevanato Group S.p.A. (STVN) Stock Analysis: Healthcare Innovator with 36% Potential Upside

In the dynamic world of healthcare and medical instruments, Stevanato Group S.p.A. (NYSE: STVN) stands out as a formidable player. With a market capitalization of $4.98..

DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst a Robust Market Position

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector’s medical care facilities industry, presents an intriguing case for investors seeking exposure to the niche market..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings Signal Promising Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology company, is rapidly gaining attention in the healthcare sector with its innovative genetic medicines. With a market capitalization..

Viatris Inc. (VTRS) Stock Analysis: Exploring the Healthcare Giant’s Valuation and Dividend Yield

Viatris Inc. (VTRS), a substantial player in the healthcare sector, has piqued the interest of investors with its expansive reach and diverse product portfolio. With a..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: High Growth Potential with a 52.61% Upside

iRhythm Holdings, Inc. (NASDAQ: IRTC), a leader in the healthcare sector specializing in medical devices, is capturing investor attention with its impressive growth trajectory and significant..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Gem with 46.76% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a compelling player in the biotechnology sector, focusing on pioneering solutions for rare neuroendocrine diseases. With a market cap of..

Biogen Inc. (BIIB) Stock Analysis: Potential 12% Upside Amid Strong Buy Ratings

Biogen Inc. (NASDAQ: BIIB), a leading player in the healthcare sector, has consistently been in the spotlight for its innovative contributions to the field of biotechnology...

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth With a 52.60% Revenue Surge

Oscar Health, Inc. (NYSE: OSCR), a key player in the healthcare technology sector, is making waves with its impressive revenue growth of 52.60%. This New York-based..

Insmed Incorporated (INSM) Stock Analysis: Exploring a 102% Potential Upside Amid Robust Revenue Growth

Investors with a keen eye on the biotechnology sector might find Insmed Incorporated (NASDAQ: INSM) an intriguing prospect, especially given its substantial potential upside of 102.12%..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Powerhouse with Growth Potential and Strategic Vision

Investors eyeing the biotechnology sector should take a closer look at Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a Dublin-based company making significant strides in the healthcare industry...

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Is a 20.50% Potential Upside Worth the Investment?

Inspire Medical Systems, Inc. (INSP), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its innovative solutions for obstructive..

Labcorp Holdings Inc. (LH) Stock Analysis: A 22% Potential Upside with Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a major player in the healthcare sector, specifically within diagnostics and research, presents an intriguing investment opportunity for those eyeing the..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech with 35.91% Potential Upside and Groundbreaking Innovations

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is making waves with its focus on developing groundbreaking muscle activators and inhibitors. Based in..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 42% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector, specifically within the medical care facilities industry, as a robust player offering comprehensive home..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds